167 related articles for article (PubMed ID: 24957381)
21. A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.
Treur M; Heeg B; Möller HJ; Schmeding A; van Hout B
BMC Health Serv Res; 2009 Feb; 9():32. PubMed ID: 19226465
[TBL] [Abstract][Full Text] [Related]
22. The impact of manufacturer coupon use in the statin market.
Daugherty JB; Maciejewski ML; Farley JF
J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
[TBL] [Abstract][Full Text] [Related]
23. The effect of switching on compliance and persistence: the case of statin treatment.
Thiebaud P; Patel BV; Nichol MB; Berenbeim DM
Am J Manag Care; 2005 Nov; 11(11):670-4. PubMed ID: 16268750
[TBL] [Abstract][Full Text] [Related]
24. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
25. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
Worthington HC; Cheng L; Majumdar SR; Morgan SG; Raymond CB; Soumerai SB; Law MR
Implement Sci; 2017 Nov; 12(1):141. PubMed ID: 29178960
[TBL] [Abstract][Full Text] [Related]
26. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.
Hansen RA; Qian J; Berg R; Linneman J; Seoane-Vazquez E; Dutcher SK; Raofi S; Page CD; Peissig P
Pharmacotherapy; 2017 Apr; 37(4):429-437. PubMed ID: 28152215
[TBL] [Abstract][Full Text] [Related]
28. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
Rathe JØ
Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
[TBL] [Abstract][Full Text] [Related]
29. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.
Degli Esposti L; Sangiorgi D; Buda S; Degli Esposti E; Scaglione F
BMJ Open; 2016 Nov; 6(11):e012003. PubMed ID: 27807083
[TBL] [Abstract][Full Text] [Related]
30. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
[TBL] [Abstract][Full Text] [Related]
31. Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching.
Italiano D; Bruno A; Santoro V; Lanza G; Muscatello MR; Zoccali R; Spina E
Ther Drug Monit; 2015 Dec; 37(6):827-30. PubMed ID: 25830930
[TBL] [Abstract][Full Text] [Related]
32. Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands.
Alfian SD; Worawutputtapong P; Schuiling-Veninga CCM; van der Schans J; Bos JHJ; Hak E; Denig P
Curr Med Res Opin; 2018 Jun; 34(6):1013-1019. PubMed ID: 29292657
[TBL] [Abstract][Full Text] [Related]
33. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.
Shrank WH; Stedman M; Ettner SL; DeLapp D; Dirstine J; Brookhart MA; Fischer MA; Avorn J; Asch SM
J Gen Intern Med; 2007 Sep; 22(9):1298-304. PubMed ID: 17647066
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
35. Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.
Marcum ZA; Huang HC; Romanelli RJ
J Gen Intern Med; 2019 Nov; 34(11):2559-2566. PubMed ID: 31367867
[TBL] [Abstract][Full Text] [Related]
36. Factors Associated With Adherence to Statin Medications of Patients Enrolled in a Self-insured University Health Plan.
Range JT; LaFontaine PR; Ryder PT; Polston M
Clin Ther; 2018 Oct; 40(10):1692-1700. PubMed ID: 30231972
[TBL] [Abstract][Full Text] [Related]
37. Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.
Colantonio LD; Deng L; Chen L; Farkouh ME; Monda KL; Harrison DJ; Maya JF; Kilgore ML; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Dec; 32(6):601-610. PubMed ID: 30446883
[TBL] [Abstract][Full Text] [Related]
38. Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.
Engelkes M; van Blijderveen JC; Overbeek JA; Kuiper J; Herings RCM; Sturkenboom MCJM; de Jongste JC; Verhamme KMC; Janssens HM
J Asthma; 2018 Oct; 55(10):1086-1094. PubMed ID: 29185812
[TBL] [Abstract][Full Text] [Related]
39. Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemia.
Cole AL; Jazowski SA; Dusetzina SB
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1529-1533. PubMed ID: 31507005
[TBL] [Abstract][Full Text] [Related]
40. Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.
Colantonio LD; Kent ST; Huang L; Chen L; Monda KL; Serban MC; Manthripragada A; Kilgore ML; Rosenson RS; Muntner P
Cardiovasc Drugs Ther; 2016 Oct; 30(5):525-533. PubMed ID: 27389413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
